Synonyms: | |
Status: | Phase 2 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | BKT5F9C2NI |
InChI Key | QJZRFPJCWMNVAV-HHHXNRCGSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C30H33ClN4O2 |
Molecular Weight | 517.07 |
AlogP | 5.59 |
Hydrogen Bond Acceptor | 5.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 9.0 |
Polar Surface Area | 81.22 |
Molecular species | BASE |
Aromatic Rings | 4.0 |
Heavy Atoms | 37.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C19
|
- | 24300 | - | - | - | |
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A4
|
- | 4100 | - | - | - | |
Enzyme
Hydrolase
|
- | - | - | - | 4 | |
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 4810 | - | - | - | |
Other cytosolic protein
|
- | 5-47 | - | 2-3 | 100 | |
Unclassified protein
|
- | - | - | - | 7 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Colonic Neoplasms | 2 | D003110 | ClinicalTrials |
Melanoma | 2 | D008545 | ClinicalTrials |
Prostatic Neoplasms | 2 | D011471 | ClinicalTrials |
Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Rectal Neoplasms | 2 | D012004 | ClinicalTrials |
Liver Neoplasms | 2 | D008113 | ClinicalTrials |
Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 336113-53-2 |
ChEBI | 94692 |
ChEMBL | CHEMBL228814 |
DrugBank | DB06188 |
EPA CompTox | DTXSID20187307 |
FDA SRS | BKT5F9C2NI |
PDB | G7X |
PubChem | 6851740 |
SureChEMBL | SCHEMBL3582165 |
ZINC | ZINC000011680799 |